Mecarocci S - Search Results

1

Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications.

Cicconi L, Bisegna M, Gurnari C, Fanciullo D, Piciocchi A, Marsili G, Minotti C, Scalzulli E, Mandelli B, Guarnera L, Perrone S, Ortu La Barbera E, Mecarocci S, Biagi A, Cenfra N, Corbingi A, Scerpa MC, Venditti A, Martelli M, Voso MT, Breccia M, Pulsoni A. Cicconi L, et al. Among authors: mecarocci s. Br J Haematol. 2024 Nov;205(5):1727-1733. doi: 10.1111/bjh.19759. Epub 2024 Sep 14. Br J Haematol. 2024. PMID: 39275865

2

Azacitidine to Consolidate and Deepen the Therapeutic Response Achieved by Intensive Induction Treatment in a Young Patient Affected by NPM1mut-AML Who Has Become Ineligible for High-Dose Consolidation.

Cenfra N, Lapietra G, Perrone S, Voso MT, Divona M, Mecarocci S, La Barbera EO, Cimino G. Cenfra N, et al. Among authors: mecarocci s. Chemotherapy. 2022;67(1):24-28. doi: 10.1159/000520205. Epub 2022 Jan 12. Chemotherapy. 2022. PMID: 35021172

3

Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role?

Breccia M, Petti MC, Ottaviani E, Mancini M, D'Elia GM, Mecarocci S, Alimena G. Breccia M, et al. Among authors: mecarocci s. Br J Haematol. 2002 Aug;118(2):438-41. doi: 10.1046/j.1365-2141.2002.03727.x. Br J Haematol. 2002. PMID: 12139729 Free article.

4

Comparison of ¹⁸F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin's lymphoma.

Panebianco M, Bagni O, Cenfra N, Mecarocci S, Ortu La Barbera E, Filippi L, Codacci-Pisanelli G, Biondi T, Laghi A, Cimino G. Panebianco M, et al. Among authors: mecarocci s. Leuk Res. 2019 Jan;76:48-52. doi: 10.1016/j.leukres.2018.11.018. Epub 2018 Dec 5. Leuk Res. 2019. PMID: 30553980

5

Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen.

Rago A, Lichtner M, Mecarocci S, Marocco R, Cenfra N, Belvisi V, Del Borgo C, Cimino G, Mastroianni CM. Rago A, et al. Among authors: mecarocci s. Antivir Ther. 2010;15(6):929-32. doi: 10.3851/IMP1633. Antivir Ther. 2010. PMID: 20834107

6

Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera.

Quattrocchi A, Maiorca C, Billi M, Tomassini S, De Marinis E, Cenfra N, Equitani F, Gentile M, Ceccherelli A, Banella C, Mecarocci S, Scerpa MC, Pisanò S, Pacilli A, Di Cristofano C, Mancini M, Guglielmelli P, Vannucchi AM, Noguera N, Grignani F, Cimino G, Nervi C. Quattrocchi A, et al. Among authors: mecarocci s. Am J Hematol. 2020 Oct;95(10):E263-E267. doi: 10.1002/ajh.25911. Epub 2020 Jul 20. Am J Hematol. 2020. PMID: 32572989 Free article. No abstract available.

7

Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and myelodysplastic syndrome rapidly evolving into acute myeloblastic leukemia.

Jaalouk G, Avvisati G, Latagliata R, Pacchiarotti A, Pulsoni A, Mecarocci S, Malagnino F. Jaalouk G, et al. Among authors: mecarocci s. Leuk Lymphoma. 1996 Apr;21(3-4):339-41. doi: 10.3109/10428199209067617. Leuk Lymphoma. 1996. PMID: 8726417

8

Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis.

Rago A, Latagliata R, Montanaro M, Montefusco E, Andriani A, Crescenzi SL, Mecarocci S, Spirito F, Spadea A, Recine U, Cicconi L, Avvisati G, Cedrone M, Breccia M, Porrini R, Villivà N, De Gregoris C, Alimena G, D'Arcangelo E, Guglielmelli P, Lo-Coco F, Vannucchi A, Cimino G. Rago A, et al. Among authors: mecarocci s. Leuk Res. 2015 Mar;39(3):314-7. doi: 10.1016/j.leukres.2015.01.001. Epub 2015 Jan 12. Leuk Res. 2015. PMID: 25636356

9

Extramedullary blast crisis occurring in a Philadelphia-positive chronic myeloid leukemia patient with major cytogenetic response to imatinib.

Breccia M, Nanni M, Mancini F, Russo E, Mecarocci S, Alimena G. Breccia M, et al. Among authors: mecarocci s. Haematologica. 2004 Apr;89(4):ECR11. Haematologica. 2004. PMID: 15075103 No abstract available.

10

A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms.

Fantasia F, Di Capua EN, Cenfra N, Pessina G, Mecarocci S, Rago A, Cotroneo E, Busanello A, Equitani F, Lo-Coco F, Nervi C, Cimino G. Fantasia F, et al. Among authors: mecarocci s. Ann Hematol. 2014 Apr;93(4):609-16. doi: 10.1007/s00277-013-1920-0. Epub 2013 Oct 31. Ann Hematol. 2014. PMID: 24173087 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters